Evidence map›Paper›PMID 39680352›Full record

ArticleInternational journal of hematology2025

Correction: Highly sensitive detection of Epstein-Barr virus-infected cells by EBER flow FISH.

Dan Tomomasa, Kay Tanita, Yuriko Hiruma, Akihiro Hoshino, Ko Kudo, Shohei Azumi, Mitsutaka Shiota, Masayoshi Yamaoka, Katsuhide Eguchi, Masataka Ishimura and 20 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Dan TomomasaDepartment of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Kay TanitaDepartment of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Yuriko HirumaFaculty of Medicine, Tokyo Medical and Dental University (TMUD), Tokyo, Japan.
Akihiro HoshinoLaboratory of Lymphocyte Activation and Susceptibility to EBV Infection, UMR 1163, INSERM, Imagine Institute, Paris, France. nrb52665@yahoo.co.jp.
Ko KudoDepartment of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Shohei AzumiDepartment of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
Mitsutaka ShiotaDepartment of Pediatrics, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Osaka, Japan.
Masayoshi YamaokaDepartment of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan.
Katsuhide EguchiDepartment of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Masataka IshimuraDepartment of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yuka TanakaDepartment of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Keiji IwatsukiDepartment of Dermatology, Okayama University Graduate School of Medicine, Okayama, Japan.
Keisuke OkunoDivision of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Yonago, Japan.
Asahito HamaDepartment of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Japan.
Ken-Ichi SakamotoDepartment of Pediatrics, Shiga University of Medical Science, Shiga, Japan.
Takashi TagaDepartment of Pediatrics, Shiga University of Medical Science, Shiga, Japan.
Kimitoshi GotoDepartment of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.
Haruka OtaDepartment of Pediatrics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Akihiro IchikiDepartment of Pediatrics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Kaori KandaDepartment of Pediatrics, Gifu Municipal Hospital, Gifu, Japan.
Takako MiyamuraDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Saori EndoDepartment of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
Hidenori OhnishiDepartment of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
Yoji SasaharaDepartment of Pediatrics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Ayako AraiDepartment of Hematology and Oncology, St. Marianna University School of Medicine, Kanagawa, Japan.
Benjamin FournierLaboratory of Lymphocyte Activation and Susceptibility to EBV Infection, UMR 1163, INSERM, Imagine Institute, Paris, France.
Ken-Ichi ImadomeDepartment for Advanced Medicine for Viral Infections, National Center for Child Health and Development, Tokyo, Japan.
Tomohiro MorioDepartment of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Sylvain LatourLaboratory of Lymphocyte Activation and Susceptibility to EBV Infection, UMR 1163, INSERM, Imagine Institute, Paris, France.
Hirokazu KaneganeDeparment of Child Health and Development, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8519, Japan. hkanegane.ped@tmd.ac.jp.ORCID http://orcid.org/0000-0002-8696-9378

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39680352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.